Nabriva Therapeutics (NBRVF) Q4 2020 Earnings

11MarExpected
Q1 2020
Q2 2020
Q3 2020
Q4 2020
-1.11
-0.79
-0.46
-0.14

Details

Expected EPS
-0.94
Actual EPS
-1.11
Surprise EPS
-0.17
Surprise Percent
+18.09%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -1.11 per share for Q4 2020.

0 Comments

Share your thoughts